The DOI matches its OpenAlex record; 54 of the 54 references it cites were found in a registry or an index.
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
Open accessAbstract
Lymphangiogenesis, an important initial step in tumor metastasis and transplant sensitization, is mediated by the action of VEGF-C and -D on VEGFR3. In contrast, VEGF-A binds VEGFR1 and VEGFR2 and is an essential hemangiogenic factor. We re-evaluated the potential role of VEGF-A in lymphangiogenesis using a novel model in which both lymphangiogenesis and hemangiogenesis are induced in the normally avascular cornea. Administration of VEGF Trap, a receptor-based fusion protein that binds and neutralizes VEGF-A but not VEGF-C or -D, completely inhibited both hemangiogenesis and the outgrowth of LYVE-1(+) lymphatic vessels following injury. Furthermore, both lymphangiogenesis and hemangiogenesis were significantly reduced in mice transgenic for VEGF-A(164/164) or VEGF-A(188/188) (each of which expresses only one of the three principle VEGF-A isoforms). Because VEGF-A is chemotactic for macrophages and we demonstrate here that macrophages in inflamed corneas release lymphangiogenic VEGF-C/VEGF-D, we evaluated the possibility that macrophage recruitment plays a role in VEGF-A-mediated lymphangiogenesis. Either systemic depletion of all bone marrow-derived cells (by irradiation) or local depletion of macrophages in the cornea (using clodronate liposomes) prior to injury significantly inhibited both hemangiogenesis and lymphangiogenesis. We conclude that VEGF-A recruitment of monocytes/macrophages plays a crucial role in inducing inflammatory neovascularization by supplying/amplifying signals essential for pathological hemangiogenesis and lymphangiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Self-citationVEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691 · cited 3×
“When added to tissue cultures at approximately equimolar concentrations, VEGF TrapR1R2 has been shown to block VEGF-A–induced phosphorylation of VEGFR2 as well as proliferation of primary human umbilical vein endothelial cells (24).”
BackgroundMethodSelf-citationLYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
Self-citationClinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Cited by
Molecular regulation of angiogenesis and lymphangiogenesis
Adams, R. H., & Alitalo, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2183 · Cited by 2,019
Tumor microenvironment as a therapeutic target in cancer
Xiao, Y., & Yu, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107753 · Cited by 1,957
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Lymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves
Cattin, A.-L., Burden, J. J., Van Emmenis, L., Mackenzie, F. E., Hoving, J. J. A., Garcia Calavia, N., Guo, Y., McLaughlin, M., Rosenberg, L. H., Quereda, V., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.021 · Cited by 936
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
The biology of vascular endothelial growth factors
TAMMELA, T., ENHOLM, B., ALITALO, K., & PAAVONEN, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.002 · Cited by 838
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., Van Rooijen, N., Takenaka, H., D’Amore, P. A., Stein-Streilein, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23874 · Cited by 712
Self-citationThe Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Jin, D. K., Shido, K., Kopp, H.-G., Petit, I., Shmelkov, S. V., Young, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1400 · Cited by 646
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M. G., Hicklin, D. J., Jeltsch, M., Petrova, T. V., Pytowski, B., Stacker, S. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522037 · Cited by 597
Self-citationLee, C. G., Link, H., Baluk, P., Homer, R. J., Chapoval, S., Bhandari, V., Kang, M. J., Cohn, L., Kim, Y. K., McDonald, D. M., et al. (2004) · Nature Medicine · doi:10.1038/nm1105 · Cited by 594
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Survey of the year 2003 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.726 · Cited by 505
Maruyama, K., Asai, J., Ii, M., Thorne, T., Losordo, D. W., & D'Amore, P. A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060018 · Cited by 492
Self-citationThe Role of Monocytes in Angiogenesis and Atherosclerosis
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.019 · Cited by 451
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., & Ren, J. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07166-8 · Cited by 447
Pathways connecting inflammation and cancer
Allavena, P., Garlanda, C., Borrello, M. G., Sica, A., & Mantovani, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.003 · Cited by 437
Cancello, R., & Clément, K. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01004.x · Cited by 418
Kataru, R. P., Jung, K., Jang, C., Yang, H., Schwendener, R. A., Baik, J. E., Han, S. H., Alitalo, K., & Koh, G. Y. (2009) · Blood · doi:10.1182/blood-2008-09-176776 · Cited by 404
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391
Interaction of tumor cells and lymphatic vessels in cancer progression
Alitalo, A., & Detmar, M. (2012) · Oncogene · doi:10.1038/onc.2011.602 · Cited by 383
Corneal Neovascularization: An Anti-VEGF Therapy Review
Chang, J.-H., Garg, N. K., Lunde, E., Han, K.-Y., Jain, S., & Azar, D. T. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.007 · Cited by 381
HIF1 α -Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages
Wang, T., Liu, H., Lian, G., Zhang, S.-Y., Wang, X., & Jiang, C. (2017) · Mediators of Inflammation · doi:10.1155/2017/9029327 · Cited by 371
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
Albuquerque, R. J. C., Hayashi, T., Cho, W. G., Kleinman, M. E., Dridi, S., Takeda, A., Baffi, J. Z., Yamada, K., Kaneko, H., Green, M. G., et al. (2009) · Nature Medicine · doi:10.1038/nm.2018 · Cited by 357
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Corliss, B. A., Azimi, M. S., Munson, J. M., Peirce, S. M., & Murfee, W. L. (2016) · Microcirculation · doi:10.1111/micc.12259 · Cited by 356
“Insulin-like growth factor 1 (IGF-1) Proangiogenic, prolymphangiogenic [28,266] IGF-2 Proangiogenic, prolymphangiogenic [28,265] IL-1a Proangiogenic, prolymphangiogenic [288,292] IL-1b Proangiogenic, prolymphangiogenic [288,292] IL-10 Antiangiogenic [299] IL-19 Proangiogenic [228] IL-20 Proangiogenic, antiangiogenic,…”
BackgroundMolecular Biology and Pathology of Lymphangiogenesis
Karpanen, T., & Alitalo, K. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151515 · Cited by 356
Cytokines as a key component of cancer-related inflammation
Germano, G., Allavena, P., & Mantovani, A. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.014 · Cited by 331
Cursiefen, C., Cao, J., Chen, L., Liu, Y., Maruyama, K., Jackson, D., Kruse, F. E., Wiegand, S. J., Dana, M. R., & Streilein, J. W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1380 · Cited by 329
Self-citationMelani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., & Colombo, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1882 · Cited by 329
Lymphangiogenic factors, mechanisms, and applications
Zheng, W., Aspelund, A., & Alitalo, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71603 · Cited by 322
Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis
Bock, F., Onderka, J., Dietrich, T., Bachmann, B., Kruse, F. E., Paschke, M., Zahn, G., & Cursiefen, C. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0570 · Cited by 320
Self-citationThe role of lymphangiogenesis and angiogenesis in tumor metastasis
Paduch, R. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0281-9 · Cited by 315
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
Cao, Y. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1693 · Cited by 307
Hos, D., Matthaei, M., Bock, F., Maruyama, K., Notara, M., Clahsen, T., Hou, Y., Le, V. N. H., Salabarria, A.-C., Horstmann, J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.001 · Cited by 303
Self-citationDietrich, T., Bock, F., Yuen, D., Hos, D., Bachmann, B. O., Zahn, G., Wiegand, S., Chen, L., & Cursiefen, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903180 · Cited by 292
Self-citationThe Lymphatic System in Health and Disease
Cueni, L. N., & Detmar, M. (2008) · Lymphatic Research and Biology · doi:10.1089/lrb.2008.1008 · Cited by 288
Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S.-I., Kimura, Y. N., Hamano, S., Sonoda, K.-H., Saijo, Y., Nukiwa, T., Strieter, R. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23298 · Cited by 286
Dose-dependent response of FGF-2 for lymphangiogenesis
Chang, L. K., Garcia-Cardeña, G., Farnebo, F., Fannon, M., Chen, E. J., Butterfield, C., Moses, M. A., Mulligan, R. C., Folkman, J., & Kaipainen, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404272101 · Cited by 276
Ritter, M. R., Banin, E., Moreno, S. K., Aguilar, E., Dorrell, M. I., & Friedlander, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29683 · Cited by 275
Inflammation and Lymphatic Function
Schwager, S., & Detmar, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00308 · Cited by 266
Macrophages regulate corpus luteum development during embryo implantation in mice
Care, A. S., Diener, K. R., Jasper, M. J., Brown, H. M., Ingman, W. V., & Robertson, S. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60561 · Cited by 263
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
Cursiefen, C., Chen, L., Saint-Geniez, M., Hamrah, P., Jin, Y., Rashid, S., Pytowski, B., Persaud, K., Wu, Y., Streilein, J. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506112103 · Cited by 262
Self-citationRole of macrophage tissue infiltration in metabolic diseases
Bouloumié, A., Curat, C. A., Sengenès, C., Lolmède, K., Miranville, A., & Busse, R. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000172571.41149.52 · Cited by 262
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Yang, L., Kwon, J., Popov, Y., Gajdos, G. B., Ordog, T., Brekken, R. A., Mukhopadhyay, D., Schuppan, D., Bi, Y., Simonetto, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.061 · Cited by 256
The role of the VEGF-C/VEGFR-3 axis in cancer progression
Su, J.-L., Yen, C.-J., Chen, P.-S., Chuang, S.-E., Hong, C.-C., Kuo, I.-H., Chen, H.-Y., Hung, M.-C., & Kuo, M.-L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603487 · Cited by 252
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
Notch signaling in developmental and tumor angiogenesis
Kofler, N. M., Shawber, C. J., Kangsamaksin, T., Reed, H. O., Galatioto, J., & Kitajewski, J. (2011) · Genes & Cancer · doi:10.1177/1947601911423030 · Cited by 142
“It has also been proposed that VEGF stimulates inflammatory lymphangiogenesis via recruitment and function of macrophages.(83) In addition to VEGF, there is increasing evidence that Ang2, via Tie2 expressed on macrophages, plays an important role in their proangiogenic activity, particularly in tumor models.”
BackgroundTopical tacrolimus for the treatment of secondary lymphedema
Gardenier, J. C., Kataru, R. P., Hespe, G. E., Savetsky, I. L., Torrisi, J. S., Nores, G. D. G., Jowhar, D. K., Nitti, M. D., Schofield, R. C., Carlow, D. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14345 · Cited by 137
Norton, L. W., Koschwanez, H. E., Wisniewski, N. A., Klitzman, B., & Reichert, W. M. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31088 · Cited by 128
Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Th2 cytokines inhibit lymphangiogenesis
Savetsky, I. L., Ghanta, S., Gardenier, J. C., Torrisi, J. S., García Nores, G. D., Hespe, G. E., Nitti, M. D., Kataru, R. P., & Mehrara, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126908 · Cited by 114
“Lymphangiogenesis is the process by which new lymphatic vessels form from pre-existing lymphatic vessels in response to pathologic stimuli such as wound healing, inflammation, and tumor metastasis [1, 2].”
Phospholipase Cγ2 is necessary for separation of blood and lymphatic vasculature in mice
Ichise, H., Ichise, T., Ohtani, O., & Yoshida, N. (2009) · Development · doi:10.1242/dev.025353 · Cited by 98
Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro
O'Neill, E. C., Qin, Q., Van Bergen, N. J., Connell, P. P., Vasudevan, S., Coote, M. A., Trounce, I. A., Wong, T. T. L., & Crowston, J. G. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5669 · Cited by 73
Hallam, T. M., Marchbank, K. J., Harris, C. L., Osmond, C., Shuttleworth, V. G., Griffiths, H., Cree, A. J., Kavanagh, D., & Lotery, A. J. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.6.18 · Cited by 57
Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
Tejera-Alhambra, M., Casrouge, A., de Andrés, C., Seyfferth, A., Ramos-Medina, R., Alonso, B., Vega, J., Fernández-Paredes, L., Albert, M. L., & Sánchez-Ramón, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128952 · Cited by 55
Masli, S., Sheibani, N., Cursiefen, C., & Zieske, J. (2014) · Current Eye Research · doi:10.3109/02713683.2013.877936 · Cited by 54
“Searching for potential other target cells, we identified a strong CD36 expression on corneal macrophages(5) which are known to play a key role in inflammatory lymphangiogenesis.(77) We therefore tested the hypothesis that TSP-1, via CD36 on macrophages, inhibits lymphangiogenesis.”
BackgroundSelf-citationNork, T. M. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.210 · Cited by 48
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
Ria, R., Melaccio, A., Racanelli, V., & Vacca, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061765 · Cited by 40
Antiangiogenesis Effect of Albendazole on the Cornea
Cho, Y. K., Shin, E. Y., Uehara, H., & Ambati, B. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0103 · Cited by 7
Metadata
- Authors
- Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2004-04-01
- Volume
- 113
- Issue
- 7
- Pages
- 1040-1050
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2065957571
- Cited by
- 1,059
- References
- 54
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.